News
- Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Comments Jul 26, 2023 The National Association of Specialty Pharmacy (NASP) welcomes the opportunity to provide comments in response to... read more
- With United Voice, Pharmacy Praises Bipartisan “Pharmacy DIR Reform” and Pharmacy Access Bill Vital for Patients, Medicare, and Pharmacies Jun 21, 2023 Washington, D.C. – Organizations representing pharmacists and pharmacies are applauding the Protect Patient Access to Pharmacies... read more
- NASP Applauds House Committee Action to Support Patient Access to Pharmacies May 25, 2023 (May 25, 2023) – This week, the House Energy and Commerce Committee passed legislation that supports... read more
- NASP Applauds Senate Actions to address Anticompetitive PBM Practices Apr 04, 2023 WASHINGTON, DC – Last week the Senate took a number of actions to address anticompetitive PBM... read more
- NASP submits testimony to U.S. Senate Committee on Finance on unfair and anticompetitive practices impacting specialty pharmacy Mar 31, 2023 The National Association of Specialty Pharmacy (NASP) submitted written testimony to the U.S. Senate Committee on... read more
- H.R. 1613 – Drug Price Transparency in Medicaid Act Mar 17, 2023 Congress Takes Action to Address Anticompetitive PBM Practices in the Medicaid Program WASHINGTON, DC – On... read more
- NASP Supports Clarification from HHS on Pandemic-Related Services at Pharmacies Jun 08, 2022 In light of the ongoing Covid-19 response, the National Association of Specialty Pharmacy (NASP) has joined... read more
- FTC Advances Study into PBM Practices and Impact on Specialty Pharmacies Jun 07, 2022 WASHINGTON, DC – The National Association of Specialty Pharmacy (NASP) applauds the decision by the Federal Trade... read more
- NASP Provides FTC Comments on PBM Business Practices and Impact on Pharmacies and Consumers May 26, 2022 On May 25, 2022, the National Association of Specialty Pharmacy (NASP) provided comments in response to... read more
- NASP Thanks Biden Administration for Reducing Out-of-Pocket Drug Costs for Seniors and Taking Initial Steps to Address Pharmacy DIR Fees May 02, 2022 Urges Congress to Work with the Administration to Protect Pharmacies as CMS Delays Implementation of The... read more